# Phase 07 gate status

Date: 2026-07-10  
Phase status: `blocked_external`  
Safe-empty software boundary: `complete_verified`

- Runtime LLM route/module/dependency: removed
- Synthetic boundary scenarios: 120 × 3 repeats
- Executable proxy report: `research/validation/safe_empty_proxy_report.json`; runner/engine/bundle SHA-256 bound
- Safe-empty determinism: 100%
- Legacy results in thesis responses: 0
- Validated claims/rules available for clinical scenario testing: 0/0
- Independent gold scenarios: 0
- Expert reviews: 0
- Synthetic blind expert queue: 120 input-linked rows; engine outputs hidden; human fields 0
- Independent gold authoring queue: 120 balanced blank rows (24 per question); authored/adjudicated gold 0
- Validated release deployment: none
- Runtime AI files/dependency: 0; empty historical directories do not count as runtime modules
- CI research gates: Phase 01/02/04/05/06, ClinicalTrials.gov, and Phase 07 proxy configured; Phase 03 raw PubMed XML rehash remains local-only

The 120 cases verify isolation and deterministic empty behavior only. They are not independent clinical gold and yield no sensitivity/precision claim. Release remains prohibited until validated claims/rules and human-independent scenarios exist.

`synthetic_scenario_inputs.jsonl` preserves the exact 120 inputs and is bound into the executable report. Reviewing those inputs may improve scenario coverage but cannot create independent gold. Gold scenarios must be independently authored twice and adjudicated in the separate blank queue.

The current public Vercel deployment is the legacy baseline at commit `33658e3`; it is not a validated thesis release. Phase 07 remains blocked until a release commit, immutable manifest, deployment identity, and post-deploy smoke evidence all match.
